Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The investigators propose the evaluation of posaconazole and benznidazole in humans for the
treatment of Chagas disease chronical infection. Exploratory trial of posaconazole
antiparasitic activity against Trypanosoma cruzi.
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Collaborators:
Hospital Vall d'Hebron International Health Unit Metropolitana Nord. Santa Coloma. Tropical Medicine and International Health Unit Drassanes. Barcelona